Presbia, maker of the Flexiview micro-lens corneal implant, sets the midpoint of the price range for its pending initial public offering at $50 million.
Presbia today set the range for its forthcoming initial public offering, saying it plans to offer 4.2 million shares at $11 to $13 apiece.
At the midpoint, the IPO would fetch $50.4 million for Presbia, which makes the Flexiview Micro-Lens corneal implant to treat presbyopia.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1y22lMQ
Cap comentari:
Publica un comentari a l'entrada